MSB Trading 2020 - a new dawn, page-4646

@Sector

Can you share the link to the article? So I can take a look at the limitations of large-scale manufacturing of iPSCs. I assume you're talking about iPSCs?

So I have two questions: I don't doubt the technology and the ability to scale in a theoretical sense, but I question the practicality of producing 30 million doses, and in what time frame? Did these scientists actually produce 30 million doses or did they just extrapolate the data? Has anyone, ever, produced 30 million doses? or near that number?

First question, when do you believe regulatory agencies will be open to approving iPSCs to treat diseases? 2 years, 5 years, 10 years, 15 years? 25 years? And are there no longer any safety concerns with the use of these cells among scientists?

Second, accessing the necessary raw materials to produce 30 million doses just doesn't seem practical to me. That's a lot of raw materials. Do you believe sourcing enough raw materials to produce 30 million doses is possible?